在多克索鲁比耐药性中miRNAs的调节作用:一种机械学观点
Fatemeh Ebadi Meinag1,2, Mina Fatahi2, Vahid Vahedian3,4,5
1Department of Biochemistry and Clinical Laboratories, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Functional & integrative genomics
|September 2, 2024
概括
微RNAs (miRNAs) 通过影响亡和p53基因来调节化疗耐药性. 本综述探讨了miRNAs如何通过PTEN/PI3K/Akt途径影响多克索鲁比辛耐药性.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 生物化学 生化学
背景情况:
- 微RNA (miRNA) 是小型非编码RNA,对于细胞周期控制和细胞亡等生物过程至关重要.
- 癌症化疗虽然是一种主要治疗,但面临着药物耐药性等挑战.
- 多克索鲁比 (DOX) 是一种广泛使用的化疗剂,但耐药性限制了其有效性.
研究的目的:
- 审查miRNAs影响癌症中多克索鲁比 (DOX) 耐药性的机制.
- 阐明miRNAs在调节亡中的作用,p53瘤抑制基因,以及DOX耐药性中的PTEN/PI3K/Akt信号通路.
主要方法:
- 关于miRNAs,多克索鲁比耐药性,亡,p53和PI3K/Akt通路的现有研究的文献综述.
- 对miRNA在化学抵抗机制中的调节作用的分析.
主要成果:
- miRNAs被确定为参与化学抵抗的基因的关键调节者.
- miRNAs调节了亡和p53通路,影响了对化疗的敏感性.
- miRNAs影响主要的生物学途径,包括PI3K/Akt信号级联,影响DOX耐药性.
结论:
- miRNAs在多克索鲁比耐药性的发展中发挥着重要作用.
- 了解miRNA介导的亡调节,p53和PTEN/PI3K/Akt通路对于克服化学抵抗至关重要.
- 向miRNAs可能提供新的治疗策略,以提高化疗的有效性.
相关概念视频
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K